Study of a New Device for Severe Asthma (PULSAR)

Clinical Trial Information

Trial Contact: Carlo, Charlene S, Melendez, Thomas L, Monserrate, Francheska, Mondragon, Diana, Colon Morales, Veronica J

IRB No: W26.189.09

Principal Investigator: Dixon, Bruce MD

Phase: N/A

Age Group: ADULTOLDER_ADULT

ClinicalTrials.gov ID: NCT07709754

Objective

To assess the feasibility and preliminary safety and efficacy of Pulmonary NeuroModulation (PNM) therapy and the implantation procedure in patients with moderate-to-severe uncontrolled asthma.

Share:

Related Clinical Trials

A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination with Rilvegostomig in Participants with High-risk Muscle Invasive Urothelial Carcinoma (TROPION-Urothelial04)
An Interventional Phase III, Open-Label, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Advanced or Recurrent Mismatch Repair Proficient Endometrial Cancer
A Randomized, Open-Label Phase III Study of Azenosertib versus Investigator's Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Multicenter research for the application and verification of the performance of the Necker Cranial Injury Scale (NCIS) as a predictor of in-hospital mortality in children and adolescents (<17 y-o) with severe traumatic brain injury (sTBI)